This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support use of the WavelinQ EndoAVF system (Becton, Dickinson and Company) for the creation of arteriovenous fistula (AVF) in patients with end-stage renal disease (ESRD) who undergo or will undergo hemodialysis.